Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David T Rubin, MD
University of Chicago
Principal Investigator - Shih-Yao Lin, MD, PhD
AltruBio Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Wellness Clinical Research (wcr)
Vega Baja, Puerto Rico
- Lynn Institute of the Ozarks
Little Rock, Arkansas, United States
- Stomach Doctor - Surinder Saini, Md - Fountain Valley
Newport Beach, California, United States
- Wellness Clinical Research (wcr)
Hialeah, Florida, United States
- Wellness Clinical Research (wcr)
Lake Wales, Florida, United States
- Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
- University of Chicago
Chicago, Illinois, United States
- Capitol Research
Rockville, Maryland, United States
- Weill Cornell Medical College
New York, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- Baylor College of Medicine
Houston, Texas, United States
- University of Washington Medical Center (uwmc) - Digestive Disease Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 May 2018
- Primary completion
- 6 Apr 2020
- Completion
- 1 Jun 2020
- Last update posted
- 5 Jan 2024
- Registered enrollment
- 24
- Registry id
- NCT03298022
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.